🔎 Trials Near Me

Pradžia › Depresija › Konektikutas

Depresija klinikiniai tyrimai Konektikutas

15 tyrimai dėl Depresija ieško dalyvių vietose Konektikutas.

Miestai Konektikutas

Oficialus tyrimo tekstas (anglų kalba)

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

  • Yale University, New Haven
Renkami dalyviai2 fazė
Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07610369

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
Renkami dalyviai3 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Cromwell
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-14 · NCT07065240

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Institute of Living, Hartford
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07076407

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

  • Mood Institute, Milford
  • Yale School of Medicine, New Haven
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT06713616

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Yale University School of Medicine, New Haven
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-06 · NCT07412756

E-Mindfulness Approaches for Living After Breast Cancer

  • Stamford Hospital/Bennett Cancer Center, Stamford
Renkami dalyviai3 fazė
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2026-08-04 · NCT06748222

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Ct Clinical Research Associates, Cromwell
Renkami dalyviai3 fazė
Amžius nuo 18 iki 74 · Visoms lytims · Atnaujinta 2026-08-03 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Cromwell
  • Neurocrine Clinical Site, Farmington
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-24 · NCT06966401

Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

  • Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine,, West Haven
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 21 iki 65 · Visoms lytims · Atnaujinta 2026-06-16 · NCT06671977

Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life

  • Yale University, New Haven
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-05-29 · NCT05810259

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

  • VA Connecticut Healthcare System, West Haven
Renkami dalyviai2 fazė
Amžius nuo 21 iki 65 · Visoms lytims · Atnaujinta 2026-05-06 · NCT05786066

Stress and Pain in People Living With HIV

  • The Yale Stress Center, New Haven
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 68 · Visoms lytims · Atnaujinta 2026-04-27 · NCT06784908

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

  • https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceL, Darien
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 44 · Moterims · Atnaujinta 2026-04-15 · NCT06788977

Open-Label Psilocybin Study in Transdiagnostic Population

  • Connecticut Mental Health Center - Yale School of Medicine, New Haven
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-11 · NCT06442423

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.